ftmarketwatch.com{7F146710-8A9B-42B6-A45C-4CB85C9F7287}&column=
Another example analysts have pointed to is the U.K.'s CeNeS Pharmaceuticals (CEN) , which has adopted a "low-risk" business model welcomed by market observers. The company balances R&D spending with a network of licensing partnerships for which it receives milestone payments and royalties.
Well that is nice to see.
I've not sold any of my CeNeS shares through the
recent decline. Maybe in a few years this one will
pull through for me. CEN.l (I think the quote is
somethign like chpaf here in the US) doesn't
bring up a quote here on SI, so I've not included it
in "Madness".
By the way, I called my portfolio "Madness" in part
becuase when I got into biotech stocks a couple years
ago, I mainly owned microcaps--and I called my basket
"Mike's Microcap Madness". I don't stick to <100M
anymore however...well, I didn't. The recent Nasdaq
crash has pulled a few things below 100M...
Finally, for tonight, I see the Cadus thread has
some activity. Fwiw, I sold a third of my Cadus over
the last month...actually, a good part of that was
the wife's, and her account got stopped out for the
year.
Is talking to yourself, blogging or whatever, unhealthy?
I wonder if it isn't similar to ruminating, a term
associated with depression. I may have to consider a
new hobby--this feels a little unhealty, and increasingly,
is starting to bore me. Maybe that is just the bear market. |
